Mei Hu and Xiang Chen
RSC Adv., 2024,14, 39653-39691
From themed collection:
2024 Reviews in RSC Advances
Abstract
Protein arginine methyltransferase 5 (PRMT5) represents a novel epigenetic anti-tumour target with significant clinical potential, and has attracted considerable interest from the academic research community and the pharmaceutical industry.
Tyler Brown, Terry Nguyen, Bo Zhou and Y. George Zheng
RSC Chem. Biol., 2023,4, 647-669
Abstract
This review provides key updates on the innovation and application of chemical approaches and tools for studying functions of PRMTs and arginine methylation in regulating biology and disease.
Yi Liu, Zheng Zhang, Huyang Du, Xiangjun Chen, Nan Hu, Tingting Yu, Meili Hou and Xiaolin Yu
RSC Adv., 2025,15, 23966-23977
Abstract
An enzyme-responsive hydrogel to co-deliver cisplatin and shRNA, targeting NED-driven chemoresistance in NSCLC.
Nardin Wagih, Islam M. Abdel-Rahman, Nawal A. El-Koussi and Gamal El-Din A. Abuo-Rahma
RSC Adv., 2025,15, 966-1010
From themed collection:
2025 Reviews in RSC Advances
Abstract
Benzimidazoles as anticancer epigenetic factors.
Piotr Raubo
Org. Biomol. Chem., 2026, Advance Article
Abstract
A spirocyclisation approach involving nucleophilic addition of lactam enolates to a range of π-deficient aromatic ring systems has been studied, delivering complex structures from readily accessible starting materials.